Fascia Iliaca vs Femoral Nerve Block in Hip Fracture Patients (CPTH)

May 13, 2026 updated by: Dr. Mehvish Saif, Central Park Teaching Hospital, Lahore

Comparative Study of Fascia Iliaca Block Versus Femoral Nerve Block for Postoperative Pain Management in Hip Fractures

Hip fractures are common orthopedic injuries, especially in older adults, and surgical repair such as hip arthroplasty is often required. Effective pain control is essential in these patients to allow proper positioning for spinal anesthesia, reduce patient discomfort, and improve overall perioperative outcomes.

Two commonly used regional anesthesia techniques for pain relief in hip fracture patients are the Fascia Iliaca Compartment Block (FICB) and the Femoral Nerve Block (FNB). Both techniques aim to block pain signals from the femoral nerve and related nerves supplying the hip region. However, there is ongoing debate regarding which technique provides better analgesia during positioning for spinal anesthesia.

This study is a prospective, randomized controlled trial conducted at Central Park Teaching Hospital, Lahore. A total of 80 patients scheduled for hip arthroplasty will be enrolled and randomly divided into two equal groups. Group A will receive Fascia Iliaca Compartment Block, while Group B will receive Femoral Nerve Block. All patients will subsequently undergo spinal anesthesia as part of standard surgical care.

The primary objective of the study is to compare the effectiveness of FICB and FNB in reducing pain during patient positioning for spinal anesthesia. Pain will be measured using the Numeric Rating Scale (NRS), which is a standard 0-10 pain scoring system, assessed before the nerve block and during positioning for spinal anesthesia.

Standard monitoring will be used in all patients, including blood pressure, pulse oximetry, and electrocardiography. Both techniques will be performed using standard local anesthetic agents. Rescue analgesia will be provided if required to ensure patient safety and comfort.

Data will be analyzed using appropriate statistical methods, and pain scores will be compared between the two groups. A p-value of ≤0.05 will be considered statistically significant.

The study aims to determine which regional anesthesia technique provides superior analgesia during spinal anesthesia positioning in hip fracture patients. The findings may help improve pain management strategies, enhance patient comfort, and optimize perioperative care in orthopedic surgery.

Study Overview

Detailed Description

Hip fractures represent a major cause of morbidity in orthopedic practice, particularly among elderly patients. Surgical management, including hemiarthroplasty or total hip arthroplasty, is frequently required to restore mobility and reduce complications associated with prolonged immobilization. Effective perioperative pain control is essential in these patients, not only to improve comfort but also to facilitate optimal positioning for neuraxial anesthesia and to reduce perioperative physiological stress responses.

Spinal anesthesia is widely preferred over general anesthesia in hip fracture surgery due to its advantages, including reduced intraoperative blood loss, lower risk of thromboembolic events, and better postoperative analgesia. However, positioning patients with acute hip fractures for spinal anesthesia is often challenging due to severe pain, which can lead to patient discomfort, hemodynamic instability, and difficulty in performing the procedure. Adequate pre-procedural analgesia is therefore essential.

Regional nerve blocks have emerged as an effective strategy for providing analgesia in hip fracture patients. Among these, the Fascia Iliaca Compartment Block (FICB) and the Femoral Nerve Block (FNB) are commonly used techniques. Both approaches aim to block sensory input from the femoral nerve and associated branches supplying the anterior thigh and hip region. Despite their widespread use, there is ongoing debate regarding their relative effectiveness, particularly in terms of pain control during positioning for spinal anesthesia.

FICB is a fascial plane block that targets the femoral nerve, lateral femoral cutaneous nerve, and occasionally the obturator nerve by depositing local anesthetic beneath the fascia iliaca. It is considered relatively easier to perform and may provide broader sensory coverage. In contrast, FNB is a more targeted nerve block that specifically anesthetizes the femoral nerve. While FNB may provide effective analgesia, its narrower coverage may limit its efficacy in certain clinical scenarios involving hip fractures.

This study is designed as a prospective, randomized, controlled clinical trial conducted at the Orthopedics Operation Theatre of Central Park Teaching Hospital, Lahore. A total of 80 patients scheduled for elective hip arthroplasty will be enrolled after meeting eligibility criteria. Participants will be randomly allocated into two equal groups using a lottery-based randomization method. Group A will receive Fascia Iliaca Compartment Block, while Group B will receive Femoral Nerve Block. All patients will subsequently undergo standard spinal anesthesia as part of routine surgical care.

Both interventions will be performed under standard aseptic conditions using established anatomical landmark techniques. A uniform local anesthetic solution will be administered in both groups to ensure comparability. Standard intraoperative monitoring, including non-invasive blood pressure, electrocardiography, and pulse oximetry, will be applied to all patients throughout the procedure.

The primary outcome measure of this study is the comparison of pain scores during positioning for spinal anesthesia between the two groups. Pain will be assessed using the Numeric Rating Scale (NRS), a validated 11-point scale ranging from 0 (no pain) to 10 (worst possible pain). Pain assessments will be recorded prior to nerve block administration and during patient positioning for spinal anesthesia.

Secondary outcomes include baseline pain scores before intervention, adequacy of sensory block assessed by pinprick and cold sensation testing, and requirement for rescue analgesia if pain exceeds acceptable thresholds. Rescue analgesia, if required, will be administered using intravenous nalbuphine in standardized doses to ensure patient comfort and safety.

Data will be collected using a structured proforma and entered into SPSS version 25 for statistical analysis. Continuous variables will be expressed as mean and standard deviation, while categorical variables will be reported as frequencies and percentages. Independent sample t-tests will be used to compare mean pain scores between groups. Chi-square tests may be applied for categorical variables where appropriate. A p-value of ≤0.05 will be considered statistically significant.

Stratified analysis will be performed based on age, gender, and body mass index to control for potential confounding factors. This will help assess the consistency of analgesic efficacy across different patient subgroups.

Ethical approval for the study has been obtained from the institutional ethics committee of Central Park Teaching Hospital, Lahore. Written informed consent will be obtained from all participants prior to enrollment. Patient confidentiality will be strictly maintained throughout the study, and participation will not interfere with standard clinical care.

The findings of this study are expected to contribute valuable evidence regarding the comparative effectiveness of Fascia Iliaca Compartment Block and Femoral Nerve Block in hip fracture patients. The results may assist anesthesiologists and orthopedic surgeons in selecting the most effective regional anesthesia technique for improving patient comfort and facilitating spinal anesthesia positioning.

Study Type

Interventional

Enrollment (Actual)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Punjab Province
      • Lahore, Punjab Province, Pakistan, 61100
        • Department of Anaesthesiology

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Both genders, age 20 to 70 years, ASA Class I and II. All cases undergoing abdominal surgery under general

Exclusion Criteria:

  • Documented cases of allergy to the drug used in study (assessed by record).
  • Documented cases with end stage liver and renal disease (ALT/ AST > 2 times normal limit or serum creatinine > 2 mg/dl).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Fascia Iliaca Compartment Block (FICB)
Patients in this arm received a Fascia Iliaca Compartment Block (FICB) prior to spinal anesthesia. The block was performed under standard aseptic precautions using the anatomical landmark technique. After negative aspiration, 0.3 ml/kg of 1.5% lignocaine with adrenaline was injected beneath the fascia iliaca to achieve analgesia of the femoral, lateral femoral cutaneous, and obturator nerve territories. Pain was assessed using the Numeric Rating Scale (NRS) during positioning for spinal anesthesia. All patients then underwent standard spinal anesthesia.
Fascia Iliaca Compartment Block (FICB) was administered prior to spinal anesthesia under aseptic conditions using the anatomical landmark technique. A needle was inserted below the inguinal ligament to access the fascia iliaca compartment. After confirmation of correct placement by loss of resistance and negative aspiration, 0.3 ml/kg of 1.5% lignocaine with adrenaline was injected. This approach aimed to block the femoral, lateral femoral cutaneous, and obturator nerves, providing broader analgesic coverage for the hip region during positioning for spinal anesthesia.
Active Comparator: Femoral Nerve Block (FNB)
Patients in this arm received a Femoral Nerve Block (FNB) before spinal anesthesia under standard aseptic conditions using anatomical landmark technique. The femoral nerve was identified lateral to the femoral artery at the inguinal crease. After negative aspiration, 0.3 ml/kg of 1.5% lignocaine with adrenaline was injected to achieve femoral nerve blockade. The block provided analgesia to the anterior thigh and hip region. Pain was assessed using the Numeric Rating Scale (NRS) during positioning for spinal anesthesia. All patients then received standard spinal anesthesia for surgery.
Fascia Iliaca Compartment Block (FICB) was administered prior to spinal anesthesia under aseptic conditions using the anatomical landmark technique. A needle was inserted below the inguinal ligament to access the fascia iliaca compartment. After confirmation of correct placement by loss of resistance and negative aspiration, 0.3 ml/kg of 1.5% lignocaine with adrenaline was injected. This approach aimed to block the femoral, lateral femoral cutaneous, and obturator nerves, providing broader analgesic coverage for the hip region during positioning for spinal anesthesia.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain score during positioning for spinal anesthesia
Time Frame: During spinal anesthesia positioning (approximately 10-15 minutes after nerve block)
Pain was measured using the Numeric Rating Scale (NRS) from 0-10, where 0 indicated no pain and 10 indicated worst pain. The score was recorded during patient positioning for spinal anesthesia after administration of Fascia Iliaca Compartment Block or Femoral Nerve Block to compare analgesic effectiveness between groups.
During spinal anesthesia positioning (approximately 10-15 minutes after nerve block)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain score before nerve block
Time Frame: Immediately before nerve block administration
Baseline pain was assessed using the Numeric Rating Scale (NRS) prior to administration of Fascia Iliaca or Femoral Nerve Block to ensure comparability between groups.
Immediately before nerve block administration
Block effectiveness (sensory assessment)
Time Frame: 5-10 minutes after nerve block administration
Effectiveness of the block was assessed using pinprick and cold sensation testing over femoral nerve distribution to confirm adequate sensory blockade after FICB or FNB.
5-10 minutes after nerve block administration
Requirement of rescue analgesia
Time Frame: During spinal anesthesia positioning
Need for rescue analgesia (intravenous nalbuphine 4 mg) was recorded if NRS score remained >4 during positioning, indicating inadequate pain control.
During spinal anesthesia positioning
Ease/duration of spinal anesthesia positioning
Time Frame: During spinal anesthesia procedure (from positioning start to successful SAB completion)
Time required for successful positioning and completion of spinal anesthesia was recorded as an indicator of analgesic effectiveness of the block.
During spinal anesthesia procedure (from positioning start to successful SAB completion)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 10, 2024

Primary Completion (Actual)

December 9, 2024

Study Completion (Actual)

December 9, 2024

Study Registration Dates

First Submitted

May 13, 2026

First Submitted That Met QC Criteria

May 13, 2026

First Posted (Actual)

May 19, 2026

Study Record Updates

Last Update Posted (Actual)

May 19, 2026

Last Update Submitted That Met QC Criteria

May 13, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe